Mark Rutstein, Vice President of Oncology Development of Bayer discusses his take on the treatment trends for 2017 and 2018, which include the growth of immunotherapy and therapy tailored to individual patients. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Treatment Trends for 2017 Include Immunotherapy and Patient-Tailored Therapy
